{"transactions":[{"id":1556407,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-28","kind":"sale","planned":true,"acquired":false,"shares":693076,"price":0.1459,"value":101119.7884,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":1080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556406,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-27","kind":"sale","planned":true,"acquired":false,"shares":306924,"price":0.1699,"value":52146.3876,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":1773076,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556405,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-26","kind":"sale","planned":true,"acquired":false,"shares":2000000,"price":0.1965,"value":393000.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":2080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556404,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-25","kind":"sale","planned":true,"acquired":false,"shares":780000,"price":0.2189,"value":170742.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4080000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556403,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-03-22","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":0.23,"value":4600.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4860000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":1556402,"issuer":{"id":15899,"kind":"organization","name":"Galera Therapeutics, Inc.","symbol":"GRTX"},"owners":[{"id":92447,"kind":"organization","name":"Altamont Pharmaceutical Holdings, LLC","position":1,"cik":"0001745878","reported_name":"Altamont Pharmaceutical Holdings, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":92448,"kind":"person","name":"Pearson Mark E.","position":2,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"See footnote 1 below"}}],"security":"Common Stock","published_at":"2024-04-01T21:36:09.000Z","date":"2024-01-11","kind":"sale","planned":true,"acquired":false,"shares":400000,"price":0.2256,"value":90240.0,"ownership":{"direct":false,"nature":"See fn."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mark Pearson is the Manager and sole Member of Altamont Pharmaceutical Holdings LLC (\"Altamont\"). Altamont owns 5,280,000 shares of Galera Therapeutics, Inc. Mark Pearson does not personally own any shares. As the Manager and sole Member of Altamont, Mark Pearson possesses the power to vote and dispose of or direct the disposition of 5,280,000 shares."}],"balance_after":4880000,"source":{"system":"sec-edgar","filing":"0001683168-24-002047","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1745878/000168316824002047/ownership.xml","form_type":"5"}},{"id":3418980,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":92448,"kind":"person","name":"Pearson Mark E.","position":1,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-09-10T22:39:22.000Z","date":"2019-09-06","kind":"grant","acquired":true,"shares":30928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option vests ratably on each of December 6, 2019, March 6, 2020, June 6, 2020 and September 6, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 6, 2019, March 6, 2020, June 6, 2020 and September 6, 2020."}],"balance_after":30928,"derivative":{"exercise_price":0.97,"expiration_date":"2029-09-05","underlying":"Common Stock","underlying_shares":30928},"source":{"system":"sec-edgar","filing":"0001213900-19-017654","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390019017654/ownership.xml","form_type":"4"}},{"id":3464874,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":92448,"kind":"person","name":"Pearson Mark E.","position":1,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-07-10T21:21:39.000Z","date":"2019-06-28","kind":"grant","acquired":true,"shares":78338,"price":0.71,"value":55619.98,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities were issued in lieu of cash compensation payable for services rendered, with the number of shares issued being calculated based upon the closing price of $0.71 on June 28, 2019. The transaction is exempt under Rule 16b-3 of the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These securities were issued in lieu of cash compensation payable for services rendered, with the number of shares issued being calculated based upon the closing price of $0.71 on June 28, 2019. The transaction is exempt under Rule 16b-3 of the Securities Exchange Act of 1934."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These securities are held by Altamont Pharmaceutical Holdings, LLC, a company for which the reporting person serves as general partner and chief executive officer. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or any other purpose."}],"balance_after":78338,"source":{"system":"sec-edgar","filing":"0001213900-19-012450","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390019012450/ownership.xml","form_type":"4"}},{"id":3789355,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":92448,"kind":"person","name":"Pearson Mark E.","position":1,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-18T00:09:48.000Z","date":"2018-10-17","kind":"purchase","acquired":true,"shares":170000,"price":1.16,"value":197200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $1.14 to $1.19. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2500000,"source":{"system":"sec-edgar","filing":"0001213900-18-014061","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390018014061/ownership.xml","form_type":"4"}},{"id":3806247,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":92448,"kind":"person","name":"Pearson Mark E.","position":1,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-28T21:07:03.000Z","date":"2018-09-27","kind":"grant","acquired":true,"shares":17964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The stock option vests ratably on each of December 27, 2018, March 27, 2019, June 27, 2019 and September 27, 2019."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests ratably on each of December 27, 2018, March 27, 2019, June 27, 2019 and September 27, 2019."}],"balance_after":17964,"derivative":{"exercise_price":1.67,"expiration_date":"2028-09-26","underlying":"Common Stock","underlying_shares":17964},"source":{"system":"sec-edgar","filing":"0001213900-18-013226","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390018013226/ownership.xml","form_type":"4"}},{"id":3861898,"issuer":{"id":8067,"kind":"organization","name":"SOLIGENIX, INC.","symbol":"SNGX"},"owners":[{"id":92448,"kind":"person","name":"Pearson Mark E.","position":1,"cik":"0001486558","reported_name":"Pearson Mark E.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-25T13:23:59.000Z","date":"2018-07-20","kind":"grant","acquired":true,"shares":1500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1500,"derivative":{"exercise_price":1.22,"exercise_date":"2018-07-20","expiration_date":"2028-07-19","underlying":"COMMON STOCK","underlying_shares":1500},"source":{"system":"sec-edgar","filing":"0001213900-18-009610","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/812796/000121390018009610/ownership.xml","form_type":"4"}}]}